Brain volume loss during the first year and physical and cognitive impairment over 3 years in naive multiple sclerosis patients under fingolimod

被引：0
|
作者：
Rojas, J. [1 ]
Sanchez, F. [1 ]
Patrucco, L. [2 ]
Papolla, A. [2 ]
Miguez, J. [3 ]
Cristiano, E. [1 ]
机构：
[1] Ctr Esclerosis Multiple Buenos Aires CEMBA, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[3] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0841
引用
收藏
页码：518 / 519
页数：2
相关论文
共 50 条
  • [1] Brain volume loss and physical and cognitive impairment in naive multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Pappolla, Agustin
    Sanchez, Francisco
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (07) : 699 - 705
  • [2] Dynamics of brain volume loss during 3 years in multiple sclerosis patients with cognitive impairment: prospective cohort study
    Rojas, J.
    Sanchez, F.
    Patrucco, L.
    Papolla, A.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 530 - 530
  • [3] Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
    Nicola De Stefano
    Diego G. Silva
    Michael H. Barnett
    CNS Drugs, 2017, 31 : 289 - 305
  • [4] Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
    De Stefano, Nicola
    Silva, Diego G.
    Barnett, Michael H.
    CNS DRUGS, 2017, 31 (04) : 289 - 305
  • [5] Brain volume loss and no evidence of disease activity over 3 years in multiple sclerosis patients under interferon beta 1 a subcutaneous treatment
    Rojas, J. I.
    Sanchez, F.
    Caro, F.
    Miguez, J.
    Patrucco, L.
    Funes, J.
    Cristiano, E.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 : 175 - 178
  • [6] Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis
    Reuter, Francoise
    Zaaraoui, Wafaa
    Crespy, Lydie
    Faivre, Anthony
    Rico, Audrey
    Malikova, Irina
    Soulier, Elisabeth
    Viout, Patrick
    Ranjeva, Jean-Philippe
    Pelletier, Jean
    Audoin, Bertrand
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (10): : 1157 - 1159
  • [7] Cognitive impairment, brain lesions volume and activity and cytokine profile in multiple sclerosis patients
    Mincev, K.
    Ilves, A.
    Kataeva, G.
    Nikiforova, I.
    Petrov, A.
    Prakhova, L.
    Pozdnyakov, A.
    Stolyarov, I.
    MULTIPLE SCLEROSIS, 2007, 13 : S229 - S229
  • [8] Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics
    Vidal-Jordana, Angela
    Sastre-Garriga, Jaume
    Perez-Miralles, Francisco
    Pareto, Deborah
    Rio, Jordi
    Auger, Cristina
    Tintore, Mar
    Rovira, Alex
    Montalban, Xavier
    JOURNAL OF NEUROIMAGING, 2016, 26 (05) : 532 - 538
  • [9] Is cognitive impairment a predictor of physical disability progression in multiple sclerosis over a five-year period?
    Abasiyanik, Zuhal
    Yigit, Pinar
    Kara, Irem
    Unal, Gozde Deniz
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 447 - 447
  • [10] Fingolimod significantly reduced brain volume loss in patients with relapsing-remitting multiple sclerosis: 4-year data from FREEDOMS extension study
    Radue, E.
    Kappos, L.
    O'Connor, P.
    Polman, C.
    Hohlfeld, R.
    Calabresi, P.
    Selmaj, K.
    de Vera, A.
    Sfikas, N.
    Zhang-Auberson, L.
    Francis, G.
    JOURNAL OF NEUROLOGY, 2012, 259 : S21 - S22
12345